Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05715372 · ClinicalTrials.gov registry record · NA
Genetic Evaluation and Modification of Lifestyles to Improve Female Life Expectancy
A NA study, sponsored by Rush University Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT05715372: Clinical Trial NA study, sponsored by Rush University Medical Center.
NCT05715372 is a NA study that was terminated before completion, run by Rush University Medical Center. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05715372, a NA study, was terminated before completion, sponsored by Rush University Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The GEMLIFE Study is a 12-month clinical trial for menopausal women. The purpose of this study is to promote an improved aging process for women in menopause through lifestyle changes. The changes will include a heart healthy diet, structured walking program, and mindfulness-based stress reduction. During the study, the investigators will monitor components of your genetic make-up that will tell us how you are aging. Investigators will also monitor bloodwork for inflammation that can affect medical conditions. Study participants may qualify if you are within 5 years of your last menstrual period and have well controlled medical conditions. There is no cost to participants to enroll in the study- only potential benefits to the participant's health and aging process.
Primary Outcome
Measurement of telomere length after 12 months of a Mediterranean diet, American Heart Association walking program, and mindfulness-based stress reduction program.
Interventions
- BEHAVIORAL Mediterranean diet
- BEHAVIORAL Mindfulness-based stress reduction
- BEHAVIORAL AHA walking program
- BEHAVIORAL Unstructured Mediterranean diet
- BEHAVIORAL Unstructured walking program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-06-22 |
| Est. Completion | 2021-06-22 |
| Phase | NA |
Why NCT05715372 stopped before completion
NCT05715372 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 5 interventions - of which Mediterranean diet is the first listed.
NCT05715372 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05715372 about?
NCT05715372 is a clinical study titled "Genetic Evaluation and Modification of Lifestyles to Improve Female Life Expectancy". The GEMLIFE Study is a 12-month clinical trial for menopausal women. The purpose of this study is to promote an improved aging process for women in menopause through lifestyle changes. The changes will include a heart healthy diet, structured walking program, and mindfulness-based stress reduction. ...
What is the current status of trial NCT05715372?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2021-06-22. Estimated completion is 2021-06-22.
What interventions are being tested in trial NCT05715372?
The interventions under investigation include: Mediterranean diet (BEHAVIORAL), Mindfulness-based stress reduction (BEHAVIORAL), AHA walking program (BEHAVIORAL), Unstructured Mediterranean diet (BEHAVIORAL), Unstructured walking program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05715372?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05715372's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI